+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Structural Biology & Molecular Modeling Techniques Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012155
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Structural Biology & Molecular Modeling Techniques Market grew from USD 11.10 billion in 2024 to USD 13.20 billion in 2025. It is expected to continue growing at a CAGR of 18.39%, reaching USD 30.58 billion by 2030.

Structural biology and molecular modeling have become cornerstones of modern scientific inquiry, providing unparalleled insights into the architecture and dynamics of biomolecules. These techniques allow researchers to visualize proteins, nucleic acids, and complex assemblies at atomic resolution, driving breakthroughs in drug design, enzyme engineering, and fundamental understanding of life processes. As technological advances converge with computational power, the field is entering a new era characterized by higher throughput, greater accuracy, and more integrated workflows. Stakeholders from academia, industry, and government are placing increased emphasis on the ability to translate structural findings into tangible therapeutic and biotechnological innovations. This executive summary sets the stage for a detailed exploration of recent paradigm shifts, regulatory challenges, market segmentation, regional dynamics, leading companies, and strategic recommendations to help decision-makers navigate this rapidly evolving landscape.

Transformative Shifts Reshaping Structural Biology and Modeling

Over the past decade, structural biology has undergone transformative shifts driven by both hardware breakthroughs and algorithmic innovations. The advent of direct-electron detectors and phase-plate technology has propelled cryo-electron microscopy to resolutions once thought impossible, while advanced pulse sequences and hyperpolarization methods have broadened the utility of nuclear magnetic resonance. Concurrently, novel light sources and detector architectures have enhanced time-resolved and anomalous dispersion studies in X-ray crystallography. On the computational front, machine learning algorithms now predict protein folding with remarkable accuracy, while molecular dynamics simulations leverage GPU acceleration to explore biomolecular motions at unprecedented timescales.

This convergence of experimental and in silico capabilities has led to seamless workflows where structural data informs computational models, and vice versa. Interdisciplinary collaborations among chemists, biophysicists, computer scientists, and engineers are becoming the norm. As a result, targets once deemed intractable-such as membrane proteins and large macromolecular assemblies-are now within reach. This section delves into these technological milestones and sets the foundation for understanding how the industry is adapting to and capitalizing on these advances.

Evaluating the Cumulative Impact of United States Tariffs in 2025

In 2025, newly implemented United States tariffs on imported scientific equipment and specialized reagents have introduced a complex set of challenges for the structural biology community. High-precision detectors, advanced sample preparation devices, and proprietary software modules now carry additional levies, driving procurement costs upward. Academic institutions and research laboratories are finding that extended lead times and elevated prices for cryo-electron microscopy detectors or NMR probeheads strain tight budgets, often forcing prioritization of core projects over exploratory initiatives.

Biotechnology firms and pharmaceutical companies, which heavily rely on cross-border supply chains for consumables like isotopically labeled samples and high-purity crystals, face increased operational expenses. These additional costs can dampen R&D throughput, slow down iterative cycles of structure-based design, and limit the scope of high-risk, high-reward investigations. To mitigate these effects, many organizations are seeking local manufacturing partners, negotiating long-term supply contracts, or increasing inventory levels-each strategy carrying its own trade-offs in capital allocation.

Despite these headwinds, the community is adapting through collaborative equipment sharing, pooled procurement agreements, and open-source software frameworks that reduce dependency on high-tariff imports. The net effect underscores the importance of flexible supply chains and strategic sourcing in maintaining the momentum of structural biology and modeling research.

Key Segmentation Insights Across Technique, Application, End-User, Hardware, and Material Types

A granular view of the market reveals nuanced dynamics across multiple dimensions. Based on technique type, cryo-electron microscopy now encompasses specialized subfields such as nanocrystallography, which accelerates microcrystal structure determination; single particle analysis, which resolves heterogeneous assemblies; and tomography, which captures three-dimensional contexts within cells. Nuclear magnetic resonance continues to diversify through dynamic nuclear polarization, offering signal enhancements; solid-state NMR, unlocking insights into non-crystalline samples; and solution-state NMR, elucidating transient conformations. Meanwhile, X-ray crystallography advances via anomalous dispersion methods for de novo phasing, high-resolution electron density mapping, and time-resolved studies probing reaction intermediates.

In terms of application, disease mechanism studies are expanding from cancer research to infectious diseases and neurodegenerative disorders. Drug discovery leverages lead optimization, structure-based drug design, and target identification workflows at an integrated pace, whereas protein engineering deploys biocatalysis, enzyme engineering, and functional protein design to create bespoke catalysts. End-user segmentation underscores the varied needs of academic institutions-ranging from collaborative projects to educational use and core research laboratories-alongside biotechnology firms focused on biopharmaceutical development, contract research initiatives, and innovative biotechnologies, and pharmaceutical companies engaged in manufacturing, quality control, and research and development.

Hardware component analysis highlights the critical role of data analysis software in molecular dynamics simulation, molecular visualization, and quantum mechanics applications. Detector technologies, including charge-coupled devices, photomultiplier tubes, and scintillation detectors, continue evolving towards higher sensitivity and faster readout. Sample preparation devices, such as automated protein crystallization platforms, electrophoresis apparatus, and advanced sample storage systems, streamline workflows and enhance reproducibility. Finally, material type distinctions-covering carbohydrate and lipid analyses like carbohydrate-lipid interaction studies, glycoprotein characterization, and lipid bilayer modeling; nucleic acid investigations across CRISPR/Cas9 structures, DNA complex mapping, and RNA interaction profiling; and protein studies of enzyme complexes, membrane proteins, and signal proteins-offer tailored approaches for specific research objectives.

Key Regional Insights Highlighting Growth Drivers and Challenges

Regional dynamics reveal distinct opportunities and constraints across the globe. In the Americas, well-established academic and industrial hubs benefit from robust funding mechanisms and a mature regulatory environment, yet face increasing competition for skilled personnel and potential disruptions from trade policy shifts. The Europe, Middle East & Africa region boasts cutting-edge infrastructure and multinational collaborations, with harmonized standards facilitating cross-border studies; however, varying national regulations and emerging markets in the Middle East and Africa present both integration challenges and growth potential. Asia-Pacific is witnessing rapid adoption of cryo-electron microscopy and advanced NMR techniques, driven by significant investments in China’s research institutes, India’s biotechnology parks, and Japan’s life science clusters. While local manufacturing capacity is expanding to alleviate supply chain constraints, intellectual property policies and talent development strategies remain critical factors in sustaining long-term growth.

Leading Companies Driving Innovation in Structural Biology and Molecular Modeling

Innovation in structural biology and molecular modeling is being propelled by a cadre of leading companies. Acellera Ltd. is at the forefront of high-performance molecular simulation platforms, enabling accurate prediction of biomolecular dynamics. Agilent Technologies, Inc. offers integrated analytical instrumentation that streamlines data acquisition for NMR and mass spectrometry workflows. Biomax Informatics AG provides specialized bioinformatics solutions, enhancing data management and structural annotation. Bruker Corporation drives advancements in both NMR spectrometers and cryo-EM detectors, catering to a wide spectrum of resolution needs. Chemical Computing Group ULC delivers drug discovery software for virtual screening and structure-based design, accelerating lead optimization. Dassault Systèmes powers molecular modeling and collaboration through its BIOVIA suite, integrating experimental and computational workflows. Illumina, Inc. influences the field by offering high-throughput sequencing platforms that complement structural studies, particularly in mapping nucleic acid interactions. Thermo Fisher Scientific Inc. rounds out the landscape with comprehensive laboratory equipment and reagents, from sample preparation devices to advanced detectors, supporting end-to-end structural biology pipelines.

Actionable Recommendations for Industry Leaders to Capitalize on Emerging Opportunities

To capitalize on emerging trends, industry leaders should adopt a multi-pronged strategy. First, investing in integrated platforms that combine cryo-EM, NMR, and X-ray crystallography capabilities can reduce workflow silos and accelerate discovery. Second, diversifying supply chains through regional manufacturing partnerships and shared procurement consortia will mitigate tariff-related risks. Third, prioritizing software and AI solutions for data analysis and model prediction will unlock deeper insights from existing datasets. Fourth, fostering cross-sector collaborations-uniting academic labs with biotech incubators and pharmaceutical R&D teams-will enable resource sharing and risk-balanced innovation.

Fifth, engaging with regulatory bodies and industry associations to advocate for harmonized standards and balanced trade policies will create a more predictable operating environment. Sixth, developing talent through specialized training programs and interdisciplinary fellowships will ensure a steady pipeline of skilled practitioners. Finally, establishing open data repositories and collaborative consortia will accelerate community-driven advances while safeguarding intellectual property.

Conclusion Reinforcing Strategic Imperatives in a Rapidly Evolving Industry

The structural biology and molecular modeling landscape is poised for continued evolution as experimental precision converges with computational power. Sustained success will depend on an organization’s ability to integrate complementary techniques, adapt to shifting trade environments, and harness advanced analytics for deeper mechanistic understanding. Regional hubs must balance investment in infrastructure with talent cultivation, while companies should align product portfolios with the nuanced needs of diverse end-users. Strategic collaborations, both within and across industries, will be essential for diffusing innovation and managing cost pressures. By adhering to these imperatives, stakeholders will be well-positioned to translate structural insights into transformative therapeutics, sustainable biocatalysts, and groundbreaking discoveries that redefine our grasp of biological systems.

Market Segmentation & Coverage

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cryo-Electron Microscopy
    • Nanocrystallography
    • Single Particle Analysis
    • Tomography
  • Nuclear Magnetic Resonance (NMR)
    • Dynamic Nuclear Polarization
    • Solid-State NMR
    • Solution-State NMR
  • X-Ray Crystallography
    • Anomalous Dispersion
    • Electron Density Mapping
    • Time-Resolved Studies
  • Disease Mechanism Studies
    • Cancer Research
    • Infectious Diseases
    • Neurodegenerative Disorders
  • Drug Discovery
    • Lead Optimization
    • Structure-Based Drug Design
    • Target Identification
  • Protein Engineering
    • Biocatalysis
    • Enzyme Engineering
    • Functional Protein Design
  • Academic Institutions
    • Collaborative Projects
    • Educational Use
    • Research Laboratories
  • Biotechnology Firms
    • Biopharmaceutical Development
    • Contract Research Initiatives
    • Innovative Biotechnologies
  • Pharmaceutical Companies
    • Manufacturing
    • Quality Control
    • Research and Development
  • Data Analysis Software
    • Molecular Dynamics Simulation
    • Molecular Visualization
    • Quantum Mechanics
  • Detectors
    • Charge-Coupled Devices
    • Photomultiplier Tubes
    • Scintillation Detectors
  • Sample Preparation Devices
    • Automated Protein Crystallization
    • Electrophoresis Apparatus
    • Sample Storage Systems
  • Carbohydrates and Lipids
    • Carbohydrate-Lipid Interaction
    • Glycoproteins
    • Lipid Bilayers
  • Nucleic Acids
    • CRISPR/Cas9 Structures
    • DNA Complexes
    • RNA Interactions
  • Proteins
    • Enzyme Complexes
    • Membrane Proteins
    • Signal Proteins

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Structural Biology & Molecular Modeling Techniques Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Acellera Ltd.
  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • Bruker Corporation
  • Chemical Computing Group ULC
  • Dassault Systemes
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Structural Biology & Molecular Modeling Techniques Market, by Technique Type
8.1. Introduction
8.2. Cryo-Electron Microscopy
8.2.1. Nanocrystallography
8.2.2. Single Particle Analysis
8.2.3. Tomography
8.3. Nuclear Magnetic Resonance (NMR)
8.3.1. Dynamic Nuclear Polarization
8.3.2. Solid-State NMR
8.3.3. Solution-State NMR
8.4. X-Ray Crystallography
8.4.1. Anomalous Dispersion
8.4.2. Electron Density Mapping
8.4.3. Time-Resolved Studies
9. Structural Biology & Molecular Modeling Techniques Market, by Application
9.1. Introduction
9.2. Disease Mechanism Studies
9.2.1. Cancer Research
9.2.2. Infectious Diseases
9.2.3. Neurodegenerative Disorders
9.3. Drug Discovery
9.3.1. Lead Optimization
9.3.2. Structure-Based Drug Design
9.3.3. Target Identification
9.4. Protein Engineering
9.4.1. Biocatalysis
9.4.2. Enzyme Engineering
9.4.3. Functional Protein Design
10. Structural Biology & Molecular Modeling Techniques Market, by End-User
10.1. Introduction
10.2. Academic Institutions
10.2.1. Collaborative Projects
10.2.2. Educational Use
10.2.3. Research Laboratories
10.3. Biotechnology Firms
10.3.1. Biopharmaceutical Development
10.3.2. Contract Research Initiatives
10.3.3. Innovative Biotechnologies
10.4. Pharmaceutical Companies
10.4.1. Manufacturing
10.4.2. Quality Control
10.4.3. Research and Development
11. Structural Biology & Molecular Modeling Techniques Market, by Hardware Component
11.1. Introduction
11.2. Data Analysis Software
11.2.1. Molecular Dynamics Simulation
11.2.2. Molecular Visualization
11.2.3. Quantum Mechanics
11.3. Detectors
11.3.1. Charge-Coupled Devices
11.3.2. Photomultiplier Tubes
11.3.3. Scintillation Detectors
11.4. Sample Preparation Devices
11.4.1. Automated Protein Crystallization
11.4.2. Electrophoresis Apparatus
11.4.3. Sample Storage Systems
12. Structural Biology & Molecular Modeling Techniques Market, by Material Type
12.1. Introduction
12.2. Carbohydrates and Lipids
12.2.1. Carbohydrate-Lipid Interaction
12.2.2. Glycoproteins
12.2.3. Lipid Bilayers
12.3. Nucleic Acids
12.3.1. CRISPR/Cas9 Structures
12.3.2. DNA Complexes
12.3.3. RNA Interactions
12.4. Proteins
12.4.1. Enzyme Complexes
12.4.2. Membrane Proteins
12.4.3. Signal Proteins
13. Americas Structural Biology & Molecular Modeling Techniques Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Structural Biology & Molecular Modeling Techniques Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Structural Biology & Molecular Modeling Techniques Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Acellera Ltd.
16.3.2. Agilent Technologies, Inc.
16.3.3. Biomax Informatics AG
16.3.4. Bruker Corporation
16.3.5. Chemical Computing Group ULC
16.3.6. Dassault Systemes
16.3.7. Illumina, Inc.
16.3.8. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET MULTI-CURRENCY
FIGURE 2. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET MULTI-LANGUAGE
FIGURE 3. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NANOCRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SINGLE PARTICLE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DYNAMIC NUCLEAR POLARIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLID-STATE NMR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SOLUTION-STATE NMR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ANOMALOUS DISPERSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ELECTRON DENSITY MAPPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TIME-RESOLVED STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STRUCTURE-BASED DRUG DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOCATALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ENZYME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY FUNCTIONAL PROTEIN DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COLLABORATIVE PROJECTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY EDUCATIONAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOPHARMACEUTICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CONTRACT RESEARCH INITIATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY INNOVATIVE BIOTECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR DYNAMICS SIMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MOLECULAR VISUALIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY QUANTUM MECHANICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CHARGE-COUPLED DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHOTOMULTIPLIER TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY AUTOMATED PROTEIN CRYSTALLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ELECTROPHORESIS APPARATUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE STORAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATE-LIPID INTERACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY GLYCOPROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY LIPID BILAYERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRISPR/CAS9 STRUCTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DNA COMPLEXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY RNA INTERACTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ENZYME COMPLEXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MEMBRANE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SIGNAL PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 89. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 130. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 147. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 148. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 149. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 150. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 151. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 153. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 154. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 155. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 157. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 158. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 159. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 160. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 161. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 162. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 163. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 164. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 165. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 166. CANADA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 169. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 170. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 171. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 173. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 174. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 175. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 178. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 179. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 180. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 181. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 185. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 186. MEXICO STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEIC ACIDS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEINS, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY TECHNIQUE TYPE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CRYO-ELECTRON MICROSCOPY, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE (NMR), 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DISEASE MECHANISM STUDIES, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PROTEIN ENGINEERING, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY ACADEMIC INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY HARDWARE COMPONENT, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DATA ANALYSIS SOFTWARE, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY DETECTORS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY SAMPLE PREPARATION DEVICES, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA STRUCTURAL BIOLOGY & MOLECULAR MODELING TECHNIQUES MARKET SIZE, BY CARBOHYDRATES AND LIPIDS, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA STRUCTURAL B

Companies Mentioned

  • Acellera Ltd.
  • Agilent Technologies, Inc.
  • Biomax Informatics AG
  • Bruker Corporation
  • Chemical Computing Group ULC
  • Dassault Systemes
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...